Gsk Share Discussion Threads

[arja] 15/1/2020 18:32

nice looking uptrending chart and more in it even if it underperforms the more dynamic AZN !

[tim 3] 15/1/2020 16:28

Brave shorting new highs would say good luck but am long lol.

[toffeeman] 15/1/2020 14:30

Wish I could post charts - but I am incompetent in that arena.

I see a wedge forming:

Top line up from 1730 last July to 1820 at the end of December

Bottom line from 1635 last October up to 1750 this month.

You could have made good points by shorting at the top and longing at the bottom.

So the next one (which I was hoping to trade) would be 1830 short 1760 close and go long.

[beckers2008] 15/1/2020 14:22

T,

On the TA front, there is no resistance up to £20 so short away at your peril!!

[tradermichael] 15/1/2020 13:25

Pfizer says the flotation could be 3 to 4 years

[toffeeman] 15/1/2020 13:25

Damn - missed it by a whisker.

[escapetohome] 15/1/2020 12:58

What about the split? This could create a lot of value? Perhaps not the time to short toffeeman.

[toffeeman] 15/1/2020 12:50

So nearly at 1830 - do I have the bottle to short?

[crossing_the_rubicon] 15/1/2020 12:15

ViiV Healthcare's Dovato OK'd in Japan
The Japan Ministry of Health, Labor and Welfare has approved ViiV Healthcare's Dovato (dolutegravir 50 mg/lamivudine 300 mg) for the treatment of HIV-1 infection in people at least 12 years old and weighing at least 40 kg.

[tradermichael] 15/1/2020 11:42

The travesty is more the failure to accurately identify the global market for this product and anticipate the need for full production capacity ahead of launch.

[crossing_the_rubicon] 15/1/2020 11:37

"The company’s Shingrix vaccine, used to defend against shingles, is a global blockbuster, widely available in the US, Germany and Canada,but Shingrix has not yet been assessed as a cost-effective treatment here in UK"

Utter travesty.

Not a very flattering picture of CEO either. Looks like lizard!

[tradermichael] 15/1/2020 07:11

Chief executive Emma Walmsley believes that the vaccine breakthroughs, together with advances in immunology and new treatments for cancer, will ensure that Glaxo’s future is secured as a leading-edge pharmaceuticals company.

The group plans to split and float off its consumer healthcare arm to existing investors in 2021 or beyond.

[philanderer] 15/1/2020 00:27

Glaxosmithkline pins hopes on vaccines pipeline after shingles jab generates blockbuster sales

[tradermichael] 14/1/2020 07:57

GlaxoSmithKline has made innovation its top priority as the drugmaker seeks to land federal approval of six drugs within the next 12 months, CEO Emma Walmsley told CNBC on Monday.

[toffeeman] 13/1/2020 12:05

Looks like a good short trade at 1830

[tradermichael] 13/1/2020 09:56

1.00000 GBP = 1.29756 USD

[grahamburn] 12/1/2020 17:19

Useful write up on Emma Walmsley's policies in full page article in Sunday Times Business News today.

[keyno] 12/1/2020 11:13

As long as our hosts allow this kind of thing to continue it will ................ waste of space.

[crossing_the_rubicon] 12/1/2020 09:59

Always dubious when a tweeter has protected their account.

"Only confirmed followers have access to @smallcappick's Tweets and complete profile. Click the "Follow" button to send a follow request."

[ianood] 12/1/2020 09:33

Stocks - The link is protected and can't be opened? Please can you advise the content?